Sep 9, 2008
11:30 AM ET
|
First Quarter Fiscal Year 2009 Financial Results Conference Call
|
Oct 21, 2008
10:00 AM PT -
12:00 PM PT
|
Annual Shareholders Meeting
Speaker: Mr. Steven King, President and Chief Executive Officer, Peregrine Pharmaceuticals, Inc.
Wyndham Hotel Orange County
3350 Avenue of the Arts
Costa Mesa, CA 92626
view map
Presentation
|
Oct 30, 2008
3:45 PM PT
|
Bio Investor Forum
|
Details on upcoming events are not yet available. Please click here to be notified of all upcoming events.
Nov 11, 2008
2:00 PM ET
|
Rodman & Renshaw Healthcare Conference
|
Oct 26, 2008
|
3rd Mayo Clinic Angiogenesis Symposium
Marriott Hotel & Mayo Clinic
Rochester, MN
"Clinical Trials with a Monoclonal Antibody Against Phosphatidylserine on Tumor Vasculature"
Click here for more information
Technology Presentation
|
Oct 13, 2008
-
Oct 16, 2008
|
AIDS Vaccine 2008 Conference
|
Oct 12, 2008
-
Oct 14, 2008
|
BioPartnering Europe 2008
|
Jul 14, 2008
11:30 AM ET
|
Fiscal Year 2008 Financial Results Conference Call
|
Day of
May 30, 2008
-
Jun 3, 2008
|
44th ASCO Annual Meeting
|
Day of
Apr 12, 2008
-
Apr 16, 2008
|
AACR Annual Meeting 2008
|
Mar 11, 2008
11:30 AM ET
|
Third Quarter FY 2008 Financial Results Conference Call
|
Feb 12, 2008
9:30 AM ET
|
BIO CEO & Investor Conference 2008
Speaker: Paul J. Lytle, CFO
Waldorf-Astoria
New York City, NY
|
Feb 8, 2008
8:00 AM PT -
12:00 PM PT
|
The 10th Annual International Symposium on Anti-Angiogenic Agents (Angio 2008)
Speaker: Alison T. Stopeck, MD
Hyatt Regency
3777 La Jolla Village Drive
La Jolla, CA 92122
view map
Conference Dates: February 7 – 9, 2008
Presentation Title: Phase I Clinical Studies of the Anti-Tumor Vasculature Antibody, Bavituximab
|
Nov 6, 2007
11:40 AM PT
|
Peregrine Pharmaceuticals at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
|
 = add file to Briefcase
|
NASD:PPHM
$0.40
+ 0.01
|
Dec 1, 2008
3:17 PM ET |
Quotes delayed at least 20 minutes. Information provided by eSignal.
|
Events & Presentations 
